Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Study of High Dose SBRT in 4 Fractions for Intermediate Risk Prostate Cancer

NCT03873090 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.

NCT NCT03873090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Study of High Dose SBRT in 4 Fractions for Intermediate Risk Prostate Cancer
Lead sponsor
Istituto Clinico Humanitas
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2013
Completion date
May 23, 2018
Enrollment
33 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer